The Oxygen Myth: Why Breathing More Won’t Give You More Energy

Walk into any wellness store and you will find canned oxygen products marketed for energy, focus, and athletic recovery. Oxygen bars promise revitalization. Nasal cannulas have become a fixture in biohacker circles. The implicit logic feels airtight: oxygen powers your cells, therefore more oxygen means more power. It is one of the most intuitive ideas in health, and one of the most thoroughly contradicted by the physiology.

The evidence, from basic respiratory mechanics to clinical trials to population epidemiology, consistently points in the opposite direction: for the vast majority of people, supplemental oxygen provides no meaningful benefit, and at higher doses can actively cause harm. The bottleneck in cellular energy production is almost never a shortage of oxygen. It is something else entirely.

I want to point out a few key points of physiology with some core arguments so that you can understand the that the practical conclusion is both clarifying and actionable. The goal should not be to increase oxygen supply but to improve the mitochondria’s ability to use the oxygen already available. It is the difference between having a full cup of water and actually drinking it.

1.  We Already Have Far More Oxygen Than We Need

Start with the numbers. At rest, the average adult consumes approximately 250 mL of oxygen per minute. During maximal exercise, this climbs to roughly 3–6 liters per minute depending on body size and fitness [1]. These are the demands. Now consider the supply.

At complete rest, we breathe approximately 5–8 liters of air per minute. Since atmospheric air is 21% oxygen, this delivers roughly 1,050–1,680 mL of oxygen per minute to the lungs. We use 250 mL of it. We return the rest, unused, with every exhale.

The surplus is not a rounding error it is a four-to-seven-fold excess. We are not oxygen-deprived at rest; we are oxygen-saturated, pulling in vastly more than our metabolism demands.

There is a key insight from mismatch between supply and consumption. Oxygen consumption is demand-driven, not supply-driven. Cells do not use more oxygen simply because more is available. It’s not like some people’s spending habits with money in the bank. They simply use what their current metabolic state requires. This is why studies consistently show that individuals breathing supplemental oxygen, including through nasal cannulas, do not actually consume more oxygen than those breathing room air, provided their lungs and blood are functioning normally [2]. The extra oxygen arrives at the tissue and is returned to the lungs still attached to hemoglobin.

2. The Math of Hemoglobin Saturation: Why More O₂ Barely Changes Anything

To understand why supplemental oxygen achieves so little in healthy individuals, it helps to work through the actual numbers of how oxygen is carried in the blood.

The blood carries oxygen in two ways: bound to hemoglobin (the vast majority) and dissolved directly in plasma (a small fraction). Hemoglobin binds 1.34 mL of oxygen per gram. With a normal hemoglobin concentration of approximately 15 g/dL, the maximum hemoglobin-bound oxygen capacity is about 20.1 mL per deciliter (201 mL/L) of blood, and this is only achievable at 100% saturation [3].

At sea level breathing room air (21% oxygen), a healthy person’s hemoglobin is approximately 97% saturated, and blood PaO₂ sits around 95 mmHg. This yields the following:

• Hemoglobin-bound O₂: 15 × 1.34 × 0.97 ≈ 19.5 mL/dL
• Dissolved O₂ (0.003 mL/dL per mmHg × 95 mmHg): ≈ 0.28 mL/dL
• Total arterial O₂ content: ≈ 19.7 mL/dL (197 mL/L)

Here is the critical physiological reality: hemoglobin saturation follows a sigmoid curve that flattens sharply above roughly 70 mmHg PaO₂. This means that once you are above ~93–94% saturation, which occurs at an inhaled oxygen fraction (FiO₂) of only approximately 17%, there is essentially no room left to add more oxygen to the hemoglobin, regardless of how much more you breathe in.

Consider what happens when you breathe higher concentrations of oxygen?

• At FiO₂ 40% (delivered via simple face mask): Total blood O₂ content rises to approximately 207 mL/L, which is an increase of only +10 mL/L over room air.
• At FiO₂ 100% (breathing pure oxygen): Total blood O₂ content rises to approximately 221 mL/L, an increase of only +23 mL/L over room air.

Even breathing pure oxygen, the theoretical maximum, adds barely 12% more oxygen to the blood than room air already provides. And those small incremental gains come almost entirely from oxygen dissolved in plasma, not from hemoglobin (which is already nearly full). The hemoglobin contributes only an additional 0.6 mL/dL by going from 97% to 100% saturation, a difference of less than 3% in Hb-bound capacity.

What about common supplemental oxygen delivery methods? A nasal cannula that raises FiO₂ from 21% to approximately 25% represents a real increase in inhaled concentration. However, because hemoglobin is already 97% saturated at 21%, that 4-point rise in FiO₂ raises bumps saturation to only ~98%. The net change in total blood oxygen content is roughly +4 mL/L, against a baseline of 197 mL/L. Again, the metabolic machinery ignores this small increase because demand, not supply, governs consumption.

The a-vO₂ difference makes this even more striking. 

The Fick Principle states that oxygen consumption equals cardiac output multiplied by the difference between arterial and mixed venous oxygen content (VO₂ = CO × [CaO₂ − CvO₂]). At rest, with a cardiac output of approximately 5 L/min, the math works out as follows:

• Arterial blood (CaO₂): ~19.8 mL/dL (~20 mL/dL)
• Mixed venous blood (CvO₂) at rest (venous O₂ saturation ~75%): ~15.2 mL/dL (~15 mL/dL)
• a-vO₂ difference: ~4.6–5 mL/dL
• O₂ delivery to tissues: 5 L/min × 198 mL/L = ~990 mL/min
• O₂ consumed: 5 L/min × 46 mL/L = ~250 mL/min
• O₂ returned unused in venous blood: 5 L/min × 152 mL/L = ~760 mL/min

In other words, approximately 77% of all oxygen delivered to the tissues is returned unused with every cardiac cycle. The venous blood leaving the muscles still holds roughly 15 mL/dL. That is about three-quarters of what was delivered. Increasing arterial O₂ content by breathing supplemental oxygen simply raises the amount returned in venous blood; it does not change how much the tissues consume, because consumption is dictated by metabolic demand, not by supply. Pushing more oxygen into a system that is already sending back 77% of what it delivers will not increase energy output.

(During maximal exercise, this picture does change: venous O₂ saturation can fall to ~20%, the a-vO₂ difference widens to ~16 mL/dL, and the body extracts roughly 80% of delivered oxygen. But even here, as we will discuss, the limiting factor is not oxygen delivery but the mitochondria’s capacity to use it.)

3. Long Breath Holds Refutes the Idea of Insufficient Oxygen.

The a-vO₂ calculation above describes what is happening dynamically, oxygen flowing in, oxygen flowing out. But the body also maintains substantial static oxygen reserves, stockpiled across multiple compartments, that put the “oxygen deficiency” narrative to rest even more decisively.

3.1 Blood oxygen stores. 

Total blood volume is approximately 5 liters. Arterial blood (~1.5 L) carries approximately 197 mL of O₂ per liter, while venous blood (~3.5 L) carries approximately 152 mL/L even at rest. Total oxygen stored in blood at any given moment is roughly 830 mL, nearly 1 L in the blood.

3.2 Lung oxygen stores. 

At maximal inhalation (total lung capacity, ~6 L), the alveolar oxygen fraction is approximately 14% (reflecting PAO₂ ~100 mmHg). This gives a lung oxygen store of approximately 840 mL, which is also nearly a full liter, sitting ready in the chest.

3.3 Myoglobin and dissolved oxygen. 

Myoglobin, the oxygen-binding protein in muscle tissue, stores a smaller but physiologically meaningful quantity of oxygen holds roughly 25–60 mL depending on muscle mass and fiber type, with trained individuals having substantially higher values. Oxygen dissolved directly in tissue fluid adds a further ~100 mL.

3.3 Total oxygen

The total is approximately 1.8 liters of oxygen that is already present in the body at any moment under resting conditions. Against a resting consumption of 250 mL per minute, this represents approximately 7 minutes’ worth of oxygen supply without taking a single breath [4].

3.4 Breath holds

This reservoir explains one of the most compelling real-world demonstrations that healthy humans are not oxygen limited. Competitive static apnea, in which athletes hold their breath motionless at the surface for extraordinary durations. Elite freedivers regularly achieve breath holds exceeding 10 minutes on atmospheric air [5]. How is this possible?

Several mechanisms converge. The mammalian diving reflex, triggered by cold water on the face and voluntary apnea, produces profound bradycardia (heart rate can fall to 20–30 beats per minute) and peripheral vasoconstriction, reducing whole-body oxygen consumption by roughly 30–50% and directing blood preferentially to the heart and brain [6]. The spleen contracts, expelling a reserve of red blood cells into circulation and adding roughly 200 mL of additional oxygen-carrying capacity [7]. Trained apnea athletes also develop higher blood volumes, elevated hemoglobin concentrations, and increased myoglobin content in skeletal muscle, all of which expand the oxygen stores described above. Taken together, a trained freediver may have total O₂ stores approaching 2.5–3 liters combined with a metabolic rate well below 150 mL/min during a maximal hold, making 10–17+ minutes theoretically achievable.

Perhaps you wonder, why then is there an urge to breath even after only 30 seconds of a breath hold since clearly is not due to a lack of oxygen. This the urge is driven primarily by rising CO₂ and falling pH, not by falling oxygen per se. Trained apnea athletes learn to suppress this CO₂-driven urge through relaxation and physiological adaptation. This distinction matters because it points to a dangerous practice of hyperventilating before a breath hold, which deliberately blowing off CO₂ before diving, and thus removes the warning signal while leaving oxygen depletion unchanged. The diver loses the urge to breathe before running out of O₂, and can lose consciousness underwater without warning, called shallow-water blackout that kills swimmers and divers every year [8]. It is a vivid and tragic illustration of the same principle: the body has more oxygen than the signaling system implies.

The freediver’s extraordinary performance on nothing more than a single breath of room air is, in a sense, a controlled experiment on the oxygen surplus argument. If we were genuinely oxygen-starved, breath holds of more than 2–3 minutes would be impossible for anyone. The fact that trained humans can sustain 10-plus-minute apneas all with metabolic processes running, the brain remaining functional, and no supplemental oxygen in sight, is direct evidence that the normal atmosphere already provides oxygen in dramatic excess of what resting human physiology requires.

4. We Exhale What We Don’t Use, Even During Maximal Exercise

Further evidence of the oxygen surplus emerges from exhaled air. At rest, we inhale air at 21% oxygen and exhale it at approximately 16% oxygen [9]. We are returning most of what we breathed in, unused.

During maximal exercise (when oxygen demand is at its peak) the situation only modestly improves. Hyperventilation (breathing more air per minute to expel CO₂) means that exhaled oxygen actually rises slightly, to approximately 17–18%, because air is being cycled through faster than the lungs can extract it. Even at our hardest physical effort, we exhale a substantial fraction of the oxygen we inhaled [10].

If the body were genuinely oxygen-deprived, this would not happen. The fact that exhaled air contains substantial oxygen even during peak exercise is a direct measurement of the surplus, that is proof that gas exchange is not the limiting step.

5. The Altitude Paradox: Less Oxygen, Better Health?

If supplemental oxygen improved health and energy, the logical corollary would be that living at altitude, where atmospheric oxygen is lower, should be harmful. The data say the opposite.

Barometric pressure falls with elevation, reducing the partial pressure of oxygen in inhaled air. At Denver, Colorado (1,609 m), the effective oxygen partial pressure is equivalent to breathing only about 17% oxygen at sea level. At Mexico City (2,240 m), the equivalent drops to roughly 15.6%. In La Paz, Bolivia (3,640 m), which is a city of over 800,000 people, residents live and thrive on the equivalent of approximately 13% oxygen by sea level standards. The summit of Mount Everest (8,849 m) exposes climbers to an effective oxygen concentration of only around 5.5% FiO₂ equivalent at sea level, yet the mountain has been summited without supplemental oxygen [11].

What epidemiology shows at these elevations should, by the oxygen-supplement logic, be alarming. Instead, it is illuminating: moderate altitude (1,500–3,000 m) is consistently associated with lower rates of cardiovascular mortality, obesity, and metabolic disease in large population studies [12, 13]. People living at altitude tend to live longer, not shorter, lives. The body adapts by increasing red blood cell mass, improving mitochondrial density, and fine-tuning oxygen extraction, rather than suffering.

This is not an argument for oxygen deprivation. Genuine high-altitude sickness is real and dangerous, and physiological acclimatization takes time. The point is more targeted: the range of oxygen availability across which human health thrives is far broader than the oxygen-supplementation narrative implies, and the relationship is not linear. The underlying principle is that more is not better, and may even be worse/harmful

6. When More Oxygen Is Actively Harmful

The case against routine oxygen supplementation is not merely that it is unhelpful. Indeed, in certain contexts, it is harmful. The medical literature on hyperoxia is unambiguous on several fronts.

6.1 During surgery. 

For decades, surgical patients were routinely given 80% or higher FiO₂ on the assumption that generous oxygen would protect tissue under physiological stress. The PROXI trial, a large randomized controlled trial published in The Lancet, compared 80% versus 30% inspired oxygen during abdominal surgery and found significantly higher one-year mortality in the high-oxygen group [14]. Subsequent meta-analyses confirmed the finding: liberal oxygen during surgery offers no survival benefit and likely increases postoperative complications, including surgical site infections, possibly because hyperoxia suppresses normal immune function [15].

6.2 In premature infants and during labor. 

Excess oxygen is particularly damaging in perinatal contexts. High FiO₂ in premature newborns drove an epidemic of retinopathy of prematurity in the 1950s and 1960s. Oxygen-induced retinal vessel damage that blinded thousands of infants before the cause was identified [16]. Neonatal hyperoxia is also toxic to the developing oligodendrocytes that form myelin in the immature brain, contributing to white matter injury and long-term neurodevelopmental impairment in very preterm survivors [17, 18]. The harm extends to the delivery room: multiple randomized controlled trials and meta-analyses have found that supplemental oxygen given to laboring women provides no benefit to neonatal outcomes compared to room air, and several trials found it actually worsened umbilical cord arterial pH, a direct measure of fetal metabolic stress [19, 20, 21].

The mechanisms are instructive: hyperoxia triggers vasoconstriction in the uteroplacental circulation, paradoxically reducing the very placental blood flow it was intended to augment; it also drives excess free radical production in fetal tissues that are developmentally calibrated for a far lower oxygen environment. The fetus normally develops at a PO₂ of approximately 20–35 mmHg (far below maternal arterial levels) because developing organ systems require, and are adapted to, a relatively hypoxic milieu during critical growth windows [22]. Hyperoxia-induced vasoconstriction is a reflexive response the body mounts across many vascular beds when it senses excess oxygen, meaning that high inhaled concentrations can paradoxically reduce blood flow to the very tissues they were meant to protect [23].

6.3 Current clinical guidelines. 

These findings have reshaped clinical practice. Modern protocols now recommend titrating supplemental oxygen only to maintain SpO₂ in a target range of 88–94% (not 98–100%) across critically ill patients, surgical patients, and those with COPD [24, 25]. The goal is adequacy, not abundance. Chasing maximal saturation is no longer considered best practice, and in many contexts has been shown to actively worsen outcomes. The body’s “full cup” does not need to be overfilled; it needs to be drunk efficiently.

7. Trained vs. Untrained: What EPO and Hyperoxia Actually Tell Us

Some of the strongest evidence that the oxygen problem is mitochondrial,  not sufficiency comes from how differently athletes and sedentary individuals respond to oxygen-boosting interventions.

Elite endurance athletes improve meaningfully with erythropoietin (EPO), hyperoxic breathing, and altitude training, which are interventions that increase O₂ delivery. Why? Because their mitochondria are so numerous and well-developed that they can extract and consume essentially all the oxygen their blood delivers. For these athletes, O₂ delivery is the limiting factor. Their cardiovascular and respiratory systems are operating near capacity, and anything that increases supply reaches a hungry consumer.

For untrained or metabolically compromised individuals, the situation is reversed. Their mitochondria are the bottleneck. Studies consistently show that EPO and supplemental oxygen produce minimal improvements in exercise capacity in untrained people. This is not because nothing is reaching the muscles, but because the muscles’ cellular machinery cannot use what is already there [26, 27]. Consider a metabolically unfit individual walking briskly. Their breathing and heart rate are adequate to deliver far more oxygen than their muscles are consuming at that pace. The oxygen is arriving; it is simply not being converted to energy efficiently. No amount of supplemental oxygen fixes a mitochondria problem.

This is further explained by the Fick Principle discussed earlier. Namely, if an untrained person’s mitochondria can only process 250 mL of O₂ per minute at rest, increasing arterial O₂ content via supplemental oxygen simply means the venous blood returns with a higher O₂ content. Oxygen consumption is determined by mitochondrial capacity and metabolic demand, not by supply. Raising the ceiling on a room when no one is near the ceiling changes nothing.

8. The Real Bottleneck: Mitochondrial Dysfunction and the Oxygen It Isn’t Using

This brings us to the central and most underappreciated finding that reframes the entire oxygen narrative. To understand it properly, we need to recognize that mitochondria serve not one but two essential roles with respect to oxygen, and that both collapse in tandem when mitochondrial function is impaired.

The first role is well known: mitochondria consume oxygen as the terminal electron acceptor in the electron transport chain, using it to drive ATP synthesis. Approximately 95% of all cellular oxygen consumption is mitochondrial [31]. This is the function most people have in mind when they picture mitochondria as “powerhouses.”

The second role is less appreciated but equally fundamental: by consuming oxygen continuously, mitochondria act as a biological oxygen sink, actively maintaining intracellular oxygen concentrations far below what the surrounding blood and tissue fluid would otherwise establish. This oxygen-buffering function is not incidental to energy production; it is a direct consequence of it, and it has profound implications for cellular health.

The numbers make this concrete. Arterial blood carries oxygen at a PO₂ of approximately 95 mmHg. But in metabolically active cells, mitochondrial consumption creates steep oxygen gradients: cytoplasmic PO₂ in a respiring cell is typically in the range of 10–20 mmHg (~13–26 µM), and the PO₂ at the inner mitochondrial membrane (where oxygen is actually consumed) falls lower still, to approximately 5–10 mmHg (~6–13 µM) [32]. Critically, cytochrome c oxidase (Complex IV), the enzyme that reduces oxygen to water, has an extraordinarily high affinity for oxygen, with a Km of only ~0.1–0.3 µM, meaning it can sustain full respiratory activity at oxygen concentrations far below what most of the cell experiences [31]. The mitochondria are, in effect, holding intracellular oxygen in a narrow, tightly controlled physiological range despite the much higher concentrations that would prevail if mitochondrial consumption were to cease.

Why does this matter? Because intracellular oxygen concentration is a primary determinant of reactive oxygen species (ROS) production. The partially reduced intermediates of the electron transport chain (particularly at Complexes I and III) react with available O₂ to generate superoxide. This reaction scales with oxygen availability. In other words, the more O₂ present in the vicinity of these complexes, the more superoxide is produced. Well-functioning mitochondria, by consuming oxygen avidly, keep local O₂ concentrations low enough to limit this leak. They are simultaneously the primary consumers of oxygen and the primary regulators of the oxygen concentration that determines how much oxidative stress the cell experiences.

Campian et al. (2004) demonstrated this relationship elegantly in cell culture. They reported that cells with approximately twice the normal cytochrome c oxidase activity produced roughly half the mitochondrial ROS at both 20% and 80% ambient oxygen. This is not because they had stronger antioxidant defenses, but because their more active electron transport chain depleted intracellular oxygen faster, reducing the substrate available for superoxide generation [33]. Conversely, when mitochondrial respiration is pharmacologically inhibited, intracellular oxygen rises immediately and substantially, often approaching the extracellular concentration [34].

What happens when mitochondrial function is impaired such as in type 2 diabetes, metabolic syndrome, obesity, and normal aging? Both roles fail simultaneously. Less ATP is produced per molecule of oxygen consumed, and the oxygen that is not consumed by the respiratory chain accumulates within the cell. The consequence is a paradox: cells that are metabolically compromised for energy production are not oxygen-starve, rather they are experiencing relative oxygen excess, with intracellular PO₂ drifting upward toward concentrations that drive oxidative stress and amplify the very dysfunction responsible for the inefficiency [28, 29]. The mitochondria lose their role as oxygen regulators at the same time they lose their role as energy producers.

Accordingly, in metabolically compromised individuals, the intervention with the most potential is not one that adds more oxygen to an already inefficiently processed system. It is one that restores the mitochondria’s capacity to consume the oxygen that is already there.

Conclusion: Fill the Cup and Drink, Don’t Just keep adding more.

The oxygen-supplementation model rests on an intuition that fails at the level of basic physiology, namely that more of the raw material (oxygen) means more output (energy). In reality, cellular energy production is governed by downstream bottlenecks, and in the overwhelming majority of people, that bottleneck is not in the lungs or the blood but the mitochondria.

We already breathe in four to seven times the oxygen we need at rest. Our hemoglobin is already nearly full at normal atmospheric concentrations. Thus, even breathing 100% pure oxygen adds only ~23 mL/L more oxygen to blood that already carries 197 mL/L. At rest, we return approximately 77% of all delivered oxygen unused in venous blood. Even at maximal exercise, we exhale 17–18% oxygen compared the 21% inhaled. The body holds roughly 1.8 liters of oxygen in reserve across blood, lungs, and muscle tissue at any given moment, which is about 7 minutes’ worth of resting supply, a fact made vivid by elite freedivers who hold their breath for more than 10 minutes on nothing but room air. Populations thriving at altitude live at effective oxygen concentrations of 13–17%, with epidemiology consistently showing better metabolic and cardiovascular outcomes, not worse. And in clinical settings, excess oxygen is now recognized to cause real harm: increased surgical mortality, neonatal tissue damage, and paradoxical vasoconstriction that reduces blood flow to the very tissues that the additional oxygen was meant to help.

The data consistently point in the direction that the body does not need more oxygen. There is already ample supply with little demand, and if demand does increase, then we simply needs to use the oxygen already there, which is a mitochondrial issue, not a respiratory one.

References

1. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
2. Fulmer JD, Snider GL. ACCP-NHLBI National Conference on Oxygen Therapy. Chest. 1984;86(2):234–247.
3. Hall JE, Guyton AC. Guyton and Hall Textbook of Medical Physiology. 14th ed. Philadelphia: Elsevier; 2021. Chapter 41.
4. Ferretti G. Extreme human breath-hold diving. European Journal of Applied Physiology. 2001;84(4):254–271.
5. Lindholm P, Lundgren CE. The physiology and pathophysiology of human breath-hold diving. Journal of Applied Physiology. 2009;106(1):284–292.
6. Panneton WM. The mammalian diving response: an enigmatic reflex to preserve life? Physiology (Bethesda).2013;28(5):284–297.
7. Schagatay E, Andersson JP, Hallén M, Pålsson B. Selected contribution: role of spleen emptying in prolonging apneas in humans. Journal of Applied Physiology. 2001;90(4):1623–1629.
8. Piantadosi CA. Pathophysiology of shallow water blackout. Undersea and Hyperbaric Medicine. 2003;30(1):3–4.
9. Comroe JH Jr. Physiology of Respiration. 2nd ed. Chicago: Year Book Medical Publishers; 1974.
10. Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia. Journal of Applied Physiology. 1999;87(6):1997–2006.
11. Grocott MP, Martin DS, Levett DZ, et al.; Caudwell Xtreme Everest Research Group. Arterial blood gases and oxygen content in climbers on Mount Everest. New England Journal of Medicine. 2009;360(2):140–149.
12. Faeh D, Gutzwiller F, Bopp M; Swiss National Cohort Study Group. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009;120(6):495–501.
13. Ezzati M, Horwitz ME, Thomas DS, et al. Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: national population-based analysis of US counties. Journal of Epidemiology & Community Health. 2012;66(7):e17.
14. Meyhoff CS, Wetterslev J, Jorgensen LN, et al.; PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA. 2009;302(14):1543–1550.
15. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. The Lancet. 2018;391(10131):1693–1705.
16. Silverman WA. Retrolental fibroplasia: a modern parable. Transactions of the American Ophthalmological Society.1980;78:664–728.
17. Gerstner B, DeSilva TM, Genz K, et al. Hyperoxia causes maturation-dependent cell death in the developing white matter. Journal of Neuroscience. 2008;28(5):1236–1245.
18. Brehmer F, Bendix I, Prager S, et al. Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS ONE. 2012;7(11):e49023.
19. Fawole B, Hofmeyr GJ. Maternal oxygen administration for fetal distress. Cochrane Database of Systematic Reviews. 2012;(12):CD000136.
20. Raghuraman N, Temming LA, Doering MM, et al. Maternal oxygen supplementation compared with room air for intrauterine resuscitation: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM. 2021;3(3):100313.
21. Qian M, Liu Q, Wang C, et al. Effect of long-duration oxygen vs room air during labor on umbilical cord venous partial pressure of oxygen: a randomized controlled trial. American Journal of Obstetrics & Gynecology.2022;227(3):492.e1–492.e11.
22. Jauniaux E, Gulbis B, Burton GJ. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus — a review. Placenta. 2003;24(Suppl A):S86–S93.
23. Smit B, Smulders YM, van der Wouden JC, Oudemans-van Straaten HM, Spoelstra-de Man AM. Hemodynamic effects of acute hyperoxia: systematic review and meta-analysis. Critical Care. 2018;22(1):45.
24. Siemieniuk RA, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018;363:k4169.
25. O’Driscoll BR, Howard LS, Earis J, Mak V; British Thoracic Society Emergency Oxygen Guideline Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1):ii1–ii90.
26. Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Medicine & Science in Sports & Exercise. 2000;32(1):70–84.
27. Boushel R, Gnaiger E, Calbet JA, et al. Muscle mitochondrial capacity exceeds maximal oxygen delivery in humans. Mitochondrion. 2011;11(2):303–307.
28. Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders — a step towards mitochondria based therapeutic strategies. Biochimica et Biophysica Acta — Molecular Basis of Disease.2017;1863(5):1066–1077.
29. Jelenik T, Roden M. Mitochondrial plasticity in obesity and diabetes mellitus. Antioxidants & Redox Signaling.2013;19(3):258–268.
30. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science. 2003;302(5652):1975–1978.
31. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiological Reviews. 1997;77(3):731–758.
32. Mori MP, Penjweini R, Knutson JR, Wang P-Y, Hwang PM. Mitochondria and oxygen homeostasis. FEBS Journal.2022;289(22):6959–6968.
33. Campian JL, Gao X, Qian M, Eaton JW. Cytochrome C oxidase activity and oxygen tolerance. Journal of Biological Chemistry. 2004;279(44):46580–46587.
34. Düssmann H, Perez-Alvarez S, Anilkumar U, Papkovsky DB, Prehn JHM. Single-cell time-lapse imaging of intracellular O₂ in response to metabolic inhibition and mitochondrial cytochrome-c release. Cell Death & Disease.2017;8(6):e2853.

---

The information in this article is intended for general educational purposes and does not constitute medical advice. Individuals should consult a qualified healthcare provider before making changes to any health regimen.